Counseling and directly observed medication for primary care buprenorphine maintenance: A pilot study

Journal of Addiction Medicine

Volumn 6, Issue 3, 2012, Pages 205-211

  Moore, Brent A ^a   Barry, Declan T ^a   Sullivan, Lynn E ^b   O'Connor, Patrick G ^b   Cutter, Christopher J ^b   Schottenfeld, Richard S ^a   Fiellin, David A ^b  

^a UT Southwestern   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine therapeutic use; Opioid related disorders; Primary health care

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; COCAINE; METHADONE; OPIATE; OXYCODONE;

ABSTINENCE; ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; COUNSELING; DETOXIFICATION; DIRECTLY OBSERVED THERAPY; DRUG DOSE REDUCTION; DRUG RETENTION; DRUG USE; EMPLOYMENT; FEASIBILITY STUDY; FEMALE; HEALTH IMPACT ASSESSMENT; HEALTH SERVICE; HUMAN; INTERMETHOD COMPARISON; LEGAL ASPECT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL HEALTH; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SATISFACTION; PHYSICIAN; PHYSICIAN MANAGEMENT; PILOT STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SELF REPORT; SOCIAL CARE; TOXICITY TESTING; TREATMENT DURATION; URINALYSIS;

ADULT; BUPRENORPHINE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIRECTLY OBSERVED THERAPY; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; PILOT PROJECTS; PRIMARY HEALTH CARE;

EID: 84871322418     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3182596492     Document Type: Article

References (34)

1. Abbott PJ, Moore BA, Delaney HD. Community reinforcement approach and relapse prevention: 12 and 18-month follow-up. J Maint Addict 2003;2: 35-50.
2. Abrahms JL. A cognitive-behavioral versus nondirective group treatment program for opioid-addicted persons: an adjunct to methadone maintenance. Int J Addict 1979;14:503-511.
3. Amass L, Bickel WK, Crean JP, Blake J, Higgins ST. Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology 1998;136:217-225.
4. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MMF, Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database System Rev 2008;(4):CD004147.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Press, 1994.
6. Arfken CL, Johanson C-E, di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J Subst Abuse Treat 2010;39: 96-104.
7. Barry DT, Moore BA, Pantalon MV, et al. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med 2007;22:242-245.
8. Bell J, Shanahan M, Mutch C, et al. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction 2007;102:1899-1907.
9. Bickel WK, Amass L, Crean JP, Badger GJ. Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology 1999;146:111-118.
10. Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol 2008;16:132-143.
11. Budney AJ, Moore BA, Rocha H, Higgins ST. Voucher-based incentives and behavior therapy for adult marijuana dependence. J Cons Clin Psychol 2006;74:307-316.
12. Carroll KM. A Cognitive-behavioral Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse, 1998.
13. Carroll KM, Ball SA, Martino S, et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiat 2008;165:881-888.
14. Carroll KM, Rounsaville BJ, Gordon LT, et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994a;51:177-187.
15. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994b;51:989-997.
16. Chawarski MC, Mazlan M, Schottenfeld RS. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial. Drug Alcohol Depend 2008;94:281-284.
17. Dasgupta N, Bailey EJ, Cicero T, et al. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Med 2010;11:1078-1091.
18. Fiellin DA, O'Connor PG, Chawarski M, Pantalon MV, Schottenfeld RS. Office versus narcotic treatment program-based buprenorphine for opioid dependence. Drug Alcohol Depend 2002;66:S55-S56.
19. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New Eng J Med 2006;355:365-374.
20. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New Eng J Med 2003;349:949-958.
21. Hayes SC, Wilson KG, Gifford EV, et al. A preliminary trial of twelve-step facilitation and acceptance and commitment therapy with polysubstanceabusing methadone-maintained opiate addicts. Behav Ther 2004;35:667-688.
22. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New Eng J Med 2000;343:1290-1297.
23. Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993;181:358-364.
24. Kraft MK, Rothbard AB, Hadley TR, McLellan AT, Asch DA. Are supplementary services provided during methadone maintenance really costeffective? Am J Psychiat 1997;154:1214-1219.
25. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008;27:309-317.
26. Longabaugh R, Morgenstern J. Cognitive-behavioral coping-skills therapy for alcohol dependence: current status and future directions. Alcohol Res Health J Natl Instit Alcohol Abuse Alcohol 1999;23:78-85.
27. McGinn LK. Cognitive behavioral therapy of depression: theory, treatment and empirical status. Am J Psychotherapy 2000;54:257-262.
28. McLellan AT, Arndt IO,Metzger DS,Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269:1953-1959.
29. Moore BA, Fazzino T, Garnet B, Cutter CJ, Barry DT. Computer-based interventions for drug use disorders: a systematic review. J Subst Abuse Treat 2011;40:215-223.
30. O'Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med 1998;105: 100-105.
31. Olatunji BO, Cisler JM, Deacon BJ. Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am 2010;33:557-577.
32. Rounsaville BJ, Carroll KM. Individual psychotherapy for drug abusers. In Comprehensive Textbook of Substance Abuse. 2nd ed. New York: Williams and Wilkins, 1992:496-508.
33. Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Thrice-weekly versus daily buprenorphine maintenance. Biol Psychiatry 2000;47:1072-1079.
34. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 1997;54:713-720